跳至主要内容
临床试验/NCT04228107
NCT04228107已完成不适用

Treatment Phenotypes for Adolescents With Asthma

University of Colorado, Denver2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2020年11月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
2
主要终点
Treatment Phenotypes

研究概览

简要总结

This study will evaluate how adolescents take their asthma medications using an electronic medication monitor.

详细描述

This study will look at how adolescents use both their controller and rescue medications using an electronic medication monitoring platform, for the period of one year. Participants will be enrolled in a medication monitoring platform, and their asthma care provider will have access to medication usage information. The study team will collect data on medication use patterns in a real world setting for 12 months per participant. Additionally, healthcare providers will be enrolled in focus groups to determine barriers and facilitators to optimal medication use for their patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
12 Years 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of asthma On an inhaled controller and rescue medication for which a propeller health device is available

排除标准

  • Other significant chronic lung disease (from problem list)
  • Cystic fibrosis
  • Chronic respiratory failure
  • Tracheostomy status
  • Intersititial lung disease
  • Significant developmental delay
  • Taking more than 3 asthma related medications
  • Primary language other than English, Spanish, Catalan, Dutch, French, German or Italian
  • Healthcare providers will be recruited as well to participate in focus groups as part of specific aim 2.

结局指标

主要结局

Treatment Phenotypes

时间窗: 12 months

The Investigators will calculate the number of participants that fall into the following treatment phenotypes: "Well controlled-good adherence", "Well controlled-poor adherence", "Poorly controlled-good adherence", "Poorly controlled-poor adherence". We had initially planned to report only these 4 groups, however there was a very clear breakdown into 9 groups-as we needed to consider a moderately controlled group and a moderately adherent group. Therefore the groups are reported as follows: Poor Adhrence, Poor control Poor adherence, moderate control poor adherence, good control Moderate adherence, poor control moderate adherence, moderate control moderate adherence, good control good adherence, poor control good adherence, moderate control good adherence, good control The investigators will use group based trajectory modeling to evaluate adherence and control phenotypes

Treatment Phenotypes

时间窗: 12 months

The Investigators will calculate the number of participants that fall into the following treatment phenotypes: "Well controlled-good adherence", "Well controlled-poor adherence", "Poorly controlled-good adherence", "Poorly controlled-poor adherence". We had initially planned to report only these 4 groups, however there was a very clear breakdown into 9 groups-as we needed to consider a moderately controlled group and a moderately adherent group. Therefore the groups are reported as follows: Poor Adhrence, Poor control Poor adherence, moderate control poor adherence, good control Moderate adherence, poor control moderate adherence, moderate control moderate adherence, good control good adherence, poor control good adherence, moderate control good adherence, good control The investigators will use group based trajectory modeling to evaluate adherence and control phenotypes

次要结局

  • Qualitative Information Regarding Barriers for Medication Use(12 months)
  • Qualitative Information Regarding Facilitators for Medication Use(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验